D.A. Davidson & Co’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.04M | Buy |
2,656
+943
| +55% | +$399K | 0.01% | 954 |
|
|
2026
Q1 | $811K | Sell |
1,713
-682
| -28% | -$343K | ﹤0.01% | 990 |
|
|
2025
Q4 | $1.12M | Buy |
2,395
+388
| +19% | +$180K | 0.01% | 853 |
|
|
2025
Q3 | $855K | Sell |
2,007
-356
| -15% | -$138K | 0.01% | 932 |
|
|
2025
Q2 | $905K | Sell |
2,363
-1,293
| -35% | -$466K | 0.01% | 843 |
|
|
2025
Q1 | $1.26M | Buy |
3,656
+931
| +34% | +$299K | 0.01% | 696 |
|
|
2024
Q4 | $818K | Sell |
2,725
-1,317
| -33% | -$460K | 0.01% | 839 |
|
|
2024
Q3 | $1.64M | Buy |
4,042
+1,536
| +61% | +$562K | 0.01% | 616 |
|
|
2024
Q2 | $805K | Sell |
2,506
-1,602
| -39% | -$521K | 0.01% | 806 |
|
|
2024
Q1 | $1.37M | Sell |
4,108
-292
| -7% | -$89.2K | 0.01% | 630 |
|
|
2023
Q4 | $1.19M | Sell |
4,400
-1,151
| -21% | -$284K | 0.01% | 652 |
|
|
2023
Q3 | $1.37M | Buy |
5,551
+374
| +7% | +$102K | 0.01% | 584 |
|
|
2023
Q2 | $1.57M | Buy |
5,177
+1,868
| +56% | +$519K | 0.02% | 557 |
|
|
2023
Q1 | $873K | Buy |
+3,309
| New | +$841K | 0.01% | 729 |
|
|
2019
Q2 | – | Sell |
-2,836
| Closed | -$368K | – | 1065 |
|
|
2019
Q1 | $368K | Sell |
2,836
-165
| -5% | -$22.2K | 0.01% | 788 |
|
|
2018
Q4 | $373K | Sell |
3,001
-460
| -13% | -$61.7K | 0.01% | 740 |
|
|
2018
Q3 | $481K | Sell |
3,461
-107
| -3% | -$13.3K | 0.01% | 723 |
|
|
2018
Q2 | $366K | Buy |
3,568
+201
| +6% | +$20.3K | 0.01% | 808 |
|
|
2018
Q1 | $327K | Sell |
3,367
-136
| -4% | -$13.2K | 0.01% | 835 |
|
|
2017
Q4 | $308K | Buy |
+3,503
| New | +$281K | 0.01% | 837 |
|
|
2017
Q3 | – | Sell |
-1,970
| Closed | -$171K | – | 1468 |
|
|
2017
Q2 | $171K | Buy |
1,970
+539
| +38% | +$45.6K | ﹤0.01% | 1026 |
|
|
2017
Q1 | $127K | Buy |
1,431
+1,045
| +271% | +$87.1K | ﹤0.01% | 1137 |
|
|
2016
Q4 | $26K | Buy |
386
+6
| +2% | +$449 | ﹤0.01% | 1844 |
|
|
2016
Q3 | $27K | Buy |
380
+124
| +48% | +$9.49K | ﹤0.01% | 1759 |
|
|
2016
Q2 | $18K | Buy |
256
+54
| +27% | +$4.26K | ﹤0.01% | 1796 |
|
|
2016
Q1 | $15K | Buy |
202
+6
| +3% | +$419 | ﹤0.01% | 1801 |
|
|
2015
Q4 | $12K | Sell |
196
-289
| -60% | -$20.2K | ﹤0.01% | 1859 |
|
|
2015
Q3 | $36K | Sell |
485
-205
| -30% | -$18.2K | ﹤0.01% | 1492 |
|
|
2015
Q2 | $60K | Buy |
690
+425
| +160% | +$34K | ﹤0.01% | 1350 |
|
|
2015
Q1 | $19K | Buy |
+265
| New | +$19K | ﹤0.01% | 1671 |
|
|
2014
Q4 | – | Sell |
-50
| Closed | -$3K | – | 2120 |
|
|
2014
Q3 | $3K | Hold |
50
| – | – | ﹤0.01% | 1994 |
|
|
2014
Q2 | $2K | Hold |
50
| – | – | ﹤0.01% | 2036 |
|
|
2014
Q1 | $2K | Hold |
50
| – | – | ﹤0.01% | 2031 |
|
|
2013
Q4 | $2K | Buy |
+50
| New | +$2.31K | ﹤0.01% | 1970 |
|
Other funds holding HCA
D.A. Davidson & Co's HCA Position: Q2 2026 in Review
D.A. Davidson & Co increased its HCA Healthcare (HCA) stake by 55% in Q2 2026, buying an estimated $399K and bringing the position to 2,656 shares worth $1.04M. The position accounts for 0.01% of the portfolio, ranked #954.
D.A. Davidson & Co first reported a position in HCA in Q4 2013 and has held it in 34 quarters since. The position peaked at $1.64M in Q3 2024. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- D.A. Davidson & Co held 2,656 shares of HCA Healthcare worth $1.04M as of Q2 2026.
- D.A. Davidson & Co bought 943 HCA Healthcare shares in Q2 2026, an estimated $399K.
- HCA Healthcare made up 0.01% of D.A. Davidson & Co's portfolio in Q2 2026, its #954 holding.
- D.A. Davidson & Co first reported a position in HCA Healthcare in Q4 2013 and has held it in 34 quarters since.
- D.A. Davidson & Co's HCA Healthcare position peaked at $1.64M in Q3 2024.
- 1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.